Financials

  • Market Capitalization 4.5389 B
  • Employee 511
  • Founded 2002
  • CEO Bradley L Campbell
  • Website www.amicusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG000PLF6N0
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-158.22
売上高対価格比率
6.92

Amicus Therapeutics Inc

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

ニュース